<i>UBA1</i> Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia.

Gurnari, Carmelo; Mannion, Peter; Pandit, Ishani; Pagliuca, Simona; Voso, Maria Teresa; Maciejewski, Jaroslaw P; Visconte, Valeria; Rogers, Heesun J

UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia.

Gurnari, Carmelo; Mannion, Peter; Pandit, Ishani; Pagliuca, Simona; Voso, Maria Teresa; Maciejewski, Jaroslaw P; Visconte, Valeria; Rogers, Heesun J.

Afiliación

Gurnari C; Translational Hematology and Oncology Research Department, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Mannion P; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Pandit I; Department of Laboratory Medicine, Cleveland Clinic, Cleveland Clinic, Cleveland, OH, USA.
Pagliuca S; Translational Hematology and Oncology Research Department, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Voso MT; Translational Hematology and Oncology Research Department, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Maciejewski JP; Service d'hématologie Clinique, Hôpital Brabois, CHRU Nancy and CNRS UMR 7365 IMoPa, Biopole de l'Université de Loarraine, Vandoeuvre les Nancy, France.
Visconte V; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Rogers HJ; Neuro-Oncohematology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy.

Hemasphere ; 6(10): e775, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36187875

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Hemasphere Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google